Global Recombinant Human Granulocyte Colony-Stimulating Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant Human Granulocyte Colony-Stimulating by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant Human Granulocyte Colony-Stimulating by Country/Region, 2017, 2022 & 2028

2.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type

2.2.1 Lenograstim (Granocyte)

2.2.2 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

2.2.3 Others

2.3 Recombinant Human Granulocyte Colony-Stimulating Sales by Type

2.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Type (2017-2022)

2.4 Recombinant Human Granulocyte Colony-Stimulating Segment by Application

2.4.1 Chemotherapy Induced Neutropenia

2.4.2 Before Blood Donation

2.4.3 Stem Cell Transplants

2.4.4 Others

2.5 Recombinant Human Granulocyte Colony-Stimulating Sales by Application

2.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Application (2017-2022)

3 Global Recombinant Human Granulocyte Colony-Stimulating by Company

3.1 Global Recombinant Human Granulocyte Colony-Stimulating Breakdown Data by Company

3.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2020-2022)

3.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2020-2022)

3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Company

3.4 Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Location Distribution

3.4.2 Players Recombinant Human Granulocyte Colony-Stimulating Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Human Granulocyte Colony-Stimulating by Geographic Region

4.1 World Historic Recombinant Human Granulocyte Colony-Stimulating Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue by Geographic Region

4.2 World Historic Recombinant Human Granulocyte Colony-Stimulating Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue by Country/Region

4.3 Americas Recombinant Human Granulocyte Colony-Stimulating Sales Growth

4.4 APAC Recombinant Human Granulocyte Colony-Stimulating Sales Growth

4.5 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth

4.6 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth

5 Americas

5.1 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Country

5.1.1 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022)

5.1.2 Americas Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022)

5.2 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Type

5.3 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Region

6.1.1 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2022)

6.1.2 APAC Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2022)

6.2 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Type

6.3 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant Human Granulocyte Colony-Stimulating by Country

7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022)

7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022)

7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type

7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating by Country

8.1.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type

8.3 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant Human Granulocyte Colony-Stimulating

10.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating

10.4 Industry Chain Structure of Recombinant Human Granulocyte Colony-Stimulating

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant Human Granulocyte Colony-Stimulating Distributors

11.3 Recombinant Human Granulocyte Colony-Stimulating Customer

12 World Forecast Review for Recombinant Human Granulocyte Colony-Stimulating by Geographic Region

12.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Region

12.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Forecast by Region (2023-2028)

12.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant Human Granulocyte Colony-Stimulating Forecast by Type

12.7 Global Recombinant Human Granulocyte Colony-Stimulating Forecast by Application

13 Key Players Analysis

13.1 Amgen

13.1.1 Amgen Company Information

13.1.2 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Main Business Overview

13.1.5 Amgen Latest Developments

13.2 Qilu Pharmaceutical

13.2.1 Qilu Pharmaceutical Company Information

13.2.2 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Qilu Pharmaceutical Main Business Overview

13.2.5 Qilu Pharmaceutical Latest Developments

13.3 Shijiazhuang Pharmaceutical

13.3.1 Shijiazhuang Pharmaceutical Company Information

13.3.2 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Shijiazhuang Pharmaceutical Main Business Overview

13.3.5 Shijiazhuang Pharmaceutical Latest Developments

13.4 Kyowa Hakko Kirin

13.4.1 Kyowa Hakko Kirin Company Information

13.4.2 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Kyowa Hakko Kirin Main Business Overview

13.4.5 Kyowa Hakko Kirin Latest Developments

13.5 Gensci

13.5.1 Gensci Company Information

13.5.2 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Gensci Main Business Overview

13.5.5 Gensci Latest Developments

13.6 Amoytop Biotech

13.6.1 Amoytop Biotech Company Information

13.6.2 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Amoytop Biotech Main Business Overview

13.6.5 Amoytop Biotech Latest Developments

13.7 Hangzhou Jiuyuan

13.7.1 Hangzhou Jiuyuan Company Information

13.7.2 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hangzhou Jiuyuan Main Business Overview

13.7.5 Hangzhou Jiuyuan Latest Developments

13.8 Huaxin

13.8.1 Huaxin Company Information

13.8.2 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Huaxin Main Business Overview

13.8.5 Huaxin Latest Developments

13.9 Triprime

13.9.1 Triprime Company Information

13.9.2 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Triprime Main Business Overview

13.9.5 Triprime Latest Developments

13.10 Sinovac

13.10.1 Sinovac Company Information

13.10.2 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sinovac Main Business Overview

13.10.5 Sinovac Latest Developments

13.11 Zhaoke

13.11.1 Zhaoke Company Information

13.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Zhaoke Main Business Overview

13.11.5 Zhaoke Latest Developments

13.12 Kawin

13.12.1 Kawin Company Information

13.12.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Offered

13.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Kawin Main Business Overview

13.12.5 Kawin Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant Human Granulocyte Colony-Stimulating Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant Human Granulocyte Colony-Stimulating Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lenograstim (Granocyte)

Table 4. Major Players of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

Table 5. Major Players of Others

Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)

Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)

Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2022) & ($ million)

Table 9. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2017-2022)

Table 10. Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Type (2017-2022) & (USD/g)

Table 11. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)

Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)

Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2022)

Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2017-2022)

Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Application (2017-2022) & (USD/g)

Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2020-2022) & (KG)

Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2020-2022)

Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2020-2022)

Table 20. Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Company (2020-2022) & (USD/g)

Table 21. Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Producing Area Distribution and Sales Area

Table 22. Players Recombinant Human Granulocyte Colony-Stimulating Products Offered

Table 23. Recombinant Human Granulocyte Colony-Stimulating Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Geographic Region (2017-2022) & (KG)

Table 27. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Geographic Region (2017-2022)

Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Country/Region (2017-2022) & (KG)

Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country/Region (2017-2022)

Table 32. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)

Table 35. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)

Table 36. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)

Table 38. Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)

Table 39. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)

Table 40. Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)

Table 41. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)

Table 42. APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2022) & (KG)

Table 43. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2017-2022)

Table 44. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2017-2022)

Table 46. APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)

Table 47. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)

Table 48. APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)

Table 49. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)

Table 50. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)

Table 51. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)

Table 52. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)

Table 54. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)

Table 55. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)

Table 56. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)

Table 57. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)

Table 59. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)

Table 63. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)

Table 65. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Recombinant Human Granulocyte Colony-Stimulating

Table 67. Key Market Challenges & Risks of Recombinant Human Granulocyte Colony-Stimulating

Table 68. Key Industry Trends of Recombinant Human Granulocyte Colony-Stimulating

Table 69. Recombinant Human Granulocyte Colony-Stimulating Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Recombinant Human Granulocyte Colony-Stimulating Distributors List

Table 72. Recombinant Human Granulocyte Colony-Stimulating Customer List

Table 73. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2023-2028) & (KG)

Table 74. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Forecast by Region

Table 75. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2023-2028) & (KG)

Table 78. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2023-2028) & (KG)

Table 80. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2023-2028) & (KG)

Table 82. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2023-2028) & (KG)

Table 84. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2023-2028) & (KG)

Table 86. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2023-2028) & (KG)

Table 90. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Application (2023-2028)

Table 93. Amgen Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 94. Amgen Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 95. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 96. Amgen Main Business

Table 97. Amgen Latest Developments

Table 98. Qilu Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 99. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 100. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 101. Qilu Pharmaceutical Main Business

Table 102. Qilu Pharmaceutical Latest Developments

Table 103. Shijiazhuang Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 104. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 105. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 106. Shijiazhuang Pharmaceutical Main Business

Table 107. Shijiazhuang Pharmaceutical Latest Developments

Table 108. Kyowa Hakko Kirin Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 109. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 110. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 111. Kyowa Hakko Kirin Main Business

Table 112. Kyowa Hakko Kirin Latest Developments

Table 113. Gensci Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 114. Gensci Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 115. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 116. Gensci Main Business

Table 117. Gensci Latest Developments

Table 118. Amoytop Biotech Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 119. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 120. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 121. Amoytop Biotech Main Business

Table 122. Amoytop Biotech Latest Developments

Table 123. Hangzhou Jiuyuan Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 124. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 125. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 126. Hangzhou Jiuyuan Main Business

Table 127. Hangzhou Jiuyuan Latest Developments

Table 128. Huaxin Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 129. Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 130. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 131. Huaxin Main Business

Table 132. Huaxin Latest Developments

Table 133. Triprime Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 134. Triprime Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 135. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 136. Triprime Main Business

Table 137. Triprime Latest Developments

Table 138. Sinovac Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 139. Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 140. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 141. Sinovac Main Business

Table 142. Sinovac Latest Developments

Table 143. Zhaoke Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 144. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 145. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 146. Zhaoke Main Business

Table 147. Zhaoke Latest Developments

Table 148. Kawin Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors

Table 149. Kawin Recombinant Human Granulocyte Colony-Stimulating Product Offered

Table 150. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 151. Kawin Main Business

Table 152. Kawin Latest Developments

List of Figures

Figure 1. Picture of Recombinant Human Granulocyte Colony-Stimulating

Figure 2. Recombinant Human Granulocyte Colony-Stimulating Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lenograstim (Granocyte)

Figure 10. Product Picture of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

Figure 11. Product Picture of Others

Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2021

Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2017-2022)

Figure 14. Recombinant Human Granulocyte Colony-Stimulating Consumed in Chemotherapy Induced Neutropenia

Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Market: Chemotherapy Induced Neutropenia (2017-2022) & (KG)

Figure 16. Recombinant Human Granulocyte Colony-Stimulating Consumed in Before Blood Donation

Figure 17. Global Recombinant Human Granulocyte Colony-Stimulating Market: Before Blood Donation (2017-2022) & (KG)

Figure 18. Recombinant Human Granulocyte Colony-Stimulating Consumed in Stem Cell Transplants

Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Market: Stem Cell Transplants (2017-2022) & (KG)

Figure 20. Recombinant Human Granulocyte Colony-Stimulating Consumed in Others

Figure 21. Global Recombinant Human Granulocyte Colony-Stimulating Market: Others (2017-2022) & (KG)

Figure 22. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)

Figure 23. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application in 2021

Figure 24. Recombinant Human Granulocyte Colony-Stimulating Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company in 2021

Figure 26. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Geographic Region in 2021

Figure 28. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2017-2022)

Figure 29. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country/Region in 2021

Figure 30. Americas Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)

Figure 31. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)

Figure 32. APAC Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)

Figure 33. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)

Figure 34. Europe Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)

Figure 35. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)

Figure 37. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)

Figure 38. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2021

Figure 39. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2021

Figure 40. United States Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2021

Figure 45. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Regions in 2021

Figure 46. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2021

Figure 53. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2021

Figure 54. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2021

Figure 61. Egypt Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Recombinant Human Granulocyte Colony-Stimulating in 2021

Figure 67. Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating

Figure 68. Industry Chain Structure of Recombinant Human Granulocyte Colony-Stimulating

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles